Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of North University, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving North University patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving North University: Texas Weight Loss - North Austin, Slim Up Austin and Bio-X Weight Loss Center (Austin). Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
Ozempic seen from North University, without the jargon. Ozempic has become the household name for GLP-1s, but it is first and foremost a diabetes treatment: for weight loss, Wegovy (same molecule, higher dose) is the official indication.
Pregnancy and breastfeeding are among the situations where these treatments are not indicated. Eligibility rests mostly on BMI and comorbidities: a higher threshold on its own, or a lower one when an associated condition like prediabetes or hypertension is present.
Around North University in Travis County, 3 weight-management practice(s) are listed locally. Associated brands include Ozempic. With a local obesity rate around 38.4% and 16.6% uninsured, demand for Ozempic runs high around North University. In this state, Texas Occupations Code §111.001; the reference body is Texas Medical Board.
Same molecule (semaglutide). Ozempic is dosed/approved for diabetes, Wegovy for chronic weight loss.
Often a BMI of 30 or higher, or 27 or higher with a weight-related comorbidity, but only the medical evaluation decides.
That is an off-label use. Many physicians prescribe it, but the FDA indication for weight loss is Wegovy (same active ingredient, semaglutide, at a higher dose).
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.